For a generic and specialty pharmaceutical manufacturer, speed to market is part of the business model. Getting safe, cost-effective products released and into customers’ hands quickly is what keeps the pipeline moving and protects margin. This company needed to improve efficiency to do exactly that, and the constraint was not in development or manufacturing. It was in the last stretch: the time to move products from bulk completion to product release.
A global specialty pharmaceutical manufacturer cut product release time 46% and reduced days in the QC lab 67%, compressing a roughly 40-day release cycle once the path from bulk completion to release was finally visible and accountable, not run on guesswork.
Global Specialty Pharmaceutical Manufacturer
Results at a Glance
46%
Product Release Time Reduction
67%
Days in Lab
85%
Time to Begin Sample Testing
Executive Brief
This global specialty pharmaceutical manufacturer needed to get products to market faster, but the stretch from bulk completion to product release had become a chokepoint. Release was averaging about 40 days, and the resulting backlog carried roughly $3.1 million in back-order impact. POWERS installed the reporting and tools the release process had been missing: QC Lab reporting to track lab efficiency, test quality, and test cycle times; a Supply Chain Operating report tying production, QC Lab, and QA metrics together; a batch-record cycle-time database to make approval and sign-off transparent; and a QC Lab staffing tool to match people to the work. With the release path finally visible and accountable, product release time fell 46%, days a sample spent in the lab dropped 67%, overall lab test cycle time fell 36%, and the time just to begin testing a sample fell 85%.
The Situation
The science was sound and the product was finished. Getting it out the door was the problem, and a roughly 40-day release cycle was leaving a backlog stranded behind QC.
For a generic and specialty pharmaceutical manufacturer, speed to market is part of the business model. Getting safe, cost-effective products released and into customers’ hands quickly is what keeps the pipeline moving and protects margin. This company needed to improve efficiency to do exactly that, and the constraint was not in development or manufacturing. It was in the last stretch: the time to move products from bulk completion to product release.
That release cycle had become problematic, averaging about 40 days. With product finished but not yet cleared, work piled up behind the release process, and the backlog carried real financial weight: roughly $3.1 million in back-order impact. Finished inventory was sitting on the wrong side of release while customers waited.
The trouble was that the release process ran without the visibility needed to manage it. There was no clear view into how the QC Lab was performing, no way to see how production, QC Lab, and QA were tracking against one another, and no transparency into where batch records sat in the approval and sign-off chain. Leadership did not need a one-time push to clear the backlog. It needed a system that made the release cycle visible, tied the contributing functions together, and held each accountable so the cycle would stay compressed.
The Diagnosis
Four structural gaps producing the same outcome from four directions.
A release cycle stretched to about 40 days
The path from bulk completion to product release averaged roughly 40 days, slow enough to strand finished product behind QC and build a backlog carrying about $3.1 million in back-order impact.
A QC Lab running without reporting
No reporting existed to monitor lab efficiency, test quality, or test cycle times. Bottlenecks inside the lab stayed invisible, so no one could see where the release cycle was actually losing time.
Production, QC Lab, and QA tracked in isolation
Performance metrics for the three functions that drive release were never tied together. Without an end-to-end view, no one could see how the handoffs across the release process were performing.
Opaque sign-off and mismatched staffing
Batch-record approval and sign-off lacked visibility and transparency, so records stalled with no clear owner, and QC Lab staffing was not matched to the workload that the lab actually carried.
What POWERS Did
Made the QC-to-release path visible and tied the contributing functions together.
POWERS treated the slow release cycle as a visibility and control problem rather than a one-time backlog to clear. The work started in the QC Lab, where POWERS implemented robust reporting tools to monitor lab efficiency, test quality, and test cycle times. For the first time, the lab’s contribution to the release cycle could be measured, and the bottlenecks that had been hiding inside it could be surfaced and worked.
In parallel, POWERS built the connective tissue the release process had been missing. A Supply Chain Operating report tied production, QC Lab, and QA performance metrics together, creating a single end-to-end view of how product moved toward release. A batch-record cycle-time database brought visibility and transparency to the approval and sign-off process, so records no longer stalled without an owner, and a QC Lab staffing tool matched people to the workload to improve staffing efficiency.
Together, these tools turned a release cycle that had run on guesswork into one that was measured, connected, and accountable at every step. With the lab, production, and QA visible against shared metrics and sign-off finally transparent, the lab cycle compressed sharply at every stage and the time to move product from bulk completion to release was cut nearly in half.
The Full Result
Four measurable gains, a release cycle and a QC lab that finally ran on visibility and accountability rather than guesswork.
46%
Product Release Time Reduction
The time to move product from bulk completion to release fell 46% from a roughly 40-day average baseline, after QC Lab reporting, a Supply Chain Operating report tying production, QC Lab, and QA together, a batch-record cycle-time database, and a QC Lab staffing tool made the release process visible and accountable.
67%
Days in Lab
The number of days a sample spent in the QC Lab fell 67% as lab reporting exposed where test time was being lost and staffing was matched to the actual workload.
85%
Time to Begin Sample Testing
The time just to begin testing a sample dropped 85% once the lab could see its own queue and the handoffs into testing were tied to shared, visible metrics.
36%
Lab Test Cycle Time
Overall lab test cycle time fell 36% as test quality, efficiency, and cycle times came under continuous measurement for the first time.
Ready to builddisciplined execution in your operation?
Every POWERS engagement starts with our intensive Discovery Process. We work with everyone on your team, identify the gaps in the five disciplines that hold execution back, and build the partnership that closes them. The results stay built long after we’re gone.
Stronger Execution. Stronger Performance.
MOS · Supply Chain
A global specialty pharmaceutical manufacturer cut product release time 46% and reduced days in the QC lab 67%, compressing a roughly 40-day release cycle once the path from bulk completion to release was finally visible and accountable, not run on guesswork.
Global Specialty Pharmaceutical Manufacturer
Executive Brief
This global specialty pharmaceutical manufacturer needed to get products to market faster, but the stretch from bulk completion to product release had become a chokepoint. Release was averaging about 40 days, and the resulting backlog carried roughly $3.1 million in back-order impact. POWERS installed the reporting and tools the release process had been missing: QC Lab reporting to track lab efficiency, test quality, and test cycle times; a Supply Chain Operating report tying production, QC Lab, and QA metrics together; a batch-record cycle-time database to make approval and sign-off transparent; and a QC Lab staffing tool to match people to the work. With the release path finally visible and accountable, product release time fell 46%, days a sample spent in the lab dropped 67%, overall lab test cycle time fell 36%, and the time just to begin testing a sample fell 85%.
Results at a Glance
46%
Product Release Time Reduction
67%
Days in Lab
85%
Time to Begin Sample Testing
The Situation
The science was sound and the product was finished. Getting it out the door was the problem, and a roughly 40-day release cycle was leaving a backlog stranded behind QC.
That release cycle had become problematic, averaging about 40 days. With product finished but not yet cleared, work piled up behind the release process, and the backlog carried real financial weight: roughly $3.1 million in back-order impact. Finished inventory was sitting on the wrong side of release while customers waited.
The trouble was that the release process ran without the visibility needed to manage it. There was no clear view into how the QC Lab was performing, no way to see how production, QC Lab, and QA were tracking against one another, and no transparency into where batch records sat in the approval and sign-off chain. Leadership did not need a one-time push to clear the backlog. It needed a system that made the release cycle visible, tied the contributing functions together, and held each accountable so the cycle would stay compressed.
The Diagnosis
Four structural gaps producing the same outcome from four directions.
A release cycle stretched to about 40 days
The path from bulk completion to product release averaged roughly 40 days, slow enough to strand finished product behind QC and build a backlog carrying about $3.1 million in back-order impact.
A QC Lab running without reporting
No reporting existed to monitor lab efficiency, test quality, or test cycle times. Bottlenecks inside the lab stayed invisible, so no one could see where the release cycle was actually losing time.
Production, QC Lab, and QA tracked in isolation
Performance metrics for the three functions that drive release were never tied together. Without an end-to-end view, no one could see how the handoffs across the release process were performing.
Opaque sign-off and mismatched staffing
Batch-record approval and sign-off lacked visibility and transparency, so records stalled with no clear owner, and QC Lab staffing was not matched to the workload that the lab actually carried.
What POWERS Did
Made the QC-to-release path visible and tied the contributing functions together.
POWERS treated the slow release cycle as a visibility and control problem rather than a one-time backlog to clear. The work started in the QC Lab, where POWERS implemented robust reporting tools to monitor lab efficiency, test quality, and test cycle times. For the first time, the lab’s contribution to the release cycle could be measured, and the bottlenecks that had been hiding inside it could be surfaced and worked.
In parallel, POWERS built the connective tissue the release process had been missing. A Supply Chain Operating report tied production, QC Lab, and QA performance metrics together, creating a single end-to-end view of how product moved toward release. A batch-record cycle-time database brought visibility and transparency to the approval and sign-off process, so records no longer stalled without an owner, and a QC Lab staffing tool matched people to the workload to improve staffing efficiency.
Together, these tools turned a release cycle that had run on guesswork into one that was measured, connected, and accountable at every step. With the lab, production, and QA visible against shared metrics and sign-off finally transparent, the lab cycle compressed sharply at every stage and the time to move product from bulk completion to release was cut nearly in half.
The Full Result
46%
Product Release Time Reduction
The time to move product from bulk completion to release fell 46% from a roughly 40-day average baseline, after QC Lab reporting, a Supply Chain Operating report tying production, QC Lab, and QA together, a batch-record cycle-time database, and a QC Lab staffing tool made the release process visible and accountable.
67%
Days in Lab
The number of days a sample spent in the QC Lab fell 67% as lab reporting exposed where test time was being lost and staffing was matched to the actual workload.
85%
Time to Begin Sample Testing
The time just to begin testing a sample dropped 85% once the lab could see its own queue and the handoffs into testing were tied to shared, visible metrics.
36%
Lab Test Cycle Time
Overall lab test cycle time fell 36% as test quality, efficiency, and cycle times came under continuous measurement for the first time.
POWERS|+1 678-971-4711|info@thepowerscompany.com|1801 Peachtree St NE, Suite 200, Atlanta, GA 303091 / 1